Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. (Q40503317)

21 September 2017

Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. (English)

1 reference

21 September 2017

3

Robert J Lefkowitz

1 reference

21 September 2017

Lan Ge

1

1 reference

21 September 2017

Sudha K Shenoy

series ordinal

2

1 reference

21 September 2017

Kathryn DeFea

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

14 October 2004

1 reference

Journal of Biological Chemistry

21 September 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 September 2017

279

1 reference

21 September 2017

53

1 reference

21 September 2017

55419-55424

1 reference

21 September 2017

Lamellipodia in invasion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Trypsin is produced by and activates protease-activated receptor-2 in human cancer colon cells: evidence for new autocrine loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Breast cell invasive potential relates to the myoepithelial phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Modified proteinase-activated receptor-1 and -2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Mechanisms of desensitization and resensitization of proteinase-activated receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M410312200

Inhibition of apoptosis in human breast cancer cells: role in tumor progression to the metastatic state

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M410312200

Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M410312200

Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1074/JBC.M410312200

Identifiers

DOI

10.1074/JBC.M410312200

1 reference

21 September 2017

1 reference